These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 22722803)

  • 1. House dust mite-specific immunotherapy alters the basal expression of T regulatory and FcεRI pathway genes.
    Pevec B; Radulovic Pevec M; Stipic Markovic A; Batista I; Rijavec M; Silar M; Kosnik M; Korosec P
    Int Arch Allergy Immunol; 2012; 159(3):287-96. PubMed ID: 22722803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maintenance-Phase Subcutaneous Immunotherapy with House Dust Mites Induces Cyclic Immunologic Effects.
    Chaoul N; Albanesi M; Giliberti L; Rossi MP; Nettis E; Di Bona D; Caiaffa MF; Macchia L
    Int Arch Allergy Immunol; 2019; 179(1):37-42. PubMed ID: 30921804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical efficacy and immunological mechanisms of sublingual and subcutaneous immunotherapy in asthmatic/rhinitis children sensitized to house dust mite: an open randomized controlled trial.
    Eifan AO; Akkoc T; Yildiz A; Keles S; Ozdemir C; Bahceciler NN; Barlan IB
    Clin Exp Allergy; 2010 Jun; 40(6):922-32. PubMed ID: 20100188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dust mite component Analysis: Identifying key allergens components for effective immunotherapy in allergic rhinitis.
    Huang J; Xiang R; Tan L; Deng Y; Tao Z; Zhang W; Xu Y
    Int Immunopharmacol; 2023 Dec; 125(Pt A):111111. PubMed ID: 37925948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sublingual immunotherapy in children with allergic rhinoconjunctivitis mono-sensitized to house-dust-mites: a double-blind-placebo-controlled randomised trial.
    Aydogan M; Eifan AO; Keles S; Akkoc T; Nursoy MA; Bahceciler NN; Barlan IB
    Respir Med; 2013 Sep; 107(9):1322-9. PubMed ID: 23886432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IgE signaling suppresses FcepsilonRIbeta expression.
    Brenzovich J; Macey M; Fernando J; Chong HJ; Barnstein B; Mirmonsef P; Morales JK; Kimura A; Cruz TD; Ryan JJ
    J Leukoc Biol; 2009 Dec; 86(6):1351-8. PubMed ID: 19741159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Engineering of major house dust mite allergens Der p 1 and Der p 2 for allergen-specific immunotherapy.
    Asturias JA; Ibarrola I; Arilla MC; Vidal C; Ferrer A; Gamboa PM; Viñuela JE; Sanz ML; Andreu C; Martínez A
    Clin Exp Allergy; 2009 Jul; 39(7):1088-98. PubMed ID: 19400901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different Responses in Induction of Allergen Specific Immunoglobulin G4 and IgE-Blocking Factors for Three Mite Subcutaneous Immunotherapy Products.
    Park KH; Lee SC; Son YW; Jeong KY; Shin YS; Shin JU; Sim da W; Park HJ; Lee JH; Lee KH; Park JW
    Yonsei Med J; 2016 Nov; 57(6):1427-34. PubMed ID: 27593871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Absence of IgE neosensitization in house dust mite allergic patients following sublingual immunotherapy.
    Baron-Bodo V; Batard T; Nguyen H; Fréreux M; Horiot S; Harwanegg C; Bergmann KC; de Beaumont O; Moingeon P
    Clin Exp Allergy; 2012 Oct; 42(10):1510-8. PubMed ID: 22994348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of one-year subcutaneous and sublingual immunotherapy on clinical and laboratory parameters in children with rhinitis and asthma: a randomized, placebo-controlled, double-blind, double-dummy study.
    Yukselen A; Kendirli SG; Yilmaz M; Altintas DU; Karakoc GB
    Int Arch Allergy Immunol; 2012; 157(3):288-98. PubMed ID: 22041501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FcεRI expression and IgE binding by dendritic cells and basophils in allergic rhinitis and upon allergen immunotherapy.
    Berings M; Gevaert P; De Ruyck N; Derycke L; Holtappels G; Pilette C; Bachert C; Lambrecht BN; Dullaers M
    Clin Exp Allergy; 2018 Aug; 48(8):970-980. PubMed ID: 29682789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-5 T-cell responses to house dust mite are associated with the development of allergen-specific IgE responses and asthma in the first 5 years of life.
    Weber-Chrysochoou C; Crisafulli D; Almqvist C; Li Q; Kemp AS; Britton WJ; Marks GB;
    J Allergy Clin Immunol; 2007 Aug; 120(2):286-92. PubMed ID: 17666216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Initial immunological changes as predictors for house dust mite immunotherapy response.
    Gómez E; Fernández TD; Doña I; Rondon C; Campo P; Gomez F; Salas M; Gonzalez M; Perkins JR; Palomares F; Blanca M; Torres MJ; Mayorga C
    Clin Exp Allergy; 2015 Oct; 45(10):1542-53. PubMed ID: 26032922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential IgE reactivity to Der p 1 and Der p 2 allergens of Dermatophagoides pteronyssinus in mite-sensitized patients.
    Taketomi EA; Silva DA; Sopelete MC; Gervásio AM; Alves R; Sung SJ
    J Investig Allergol Clin Immunol; 2006; 16(2):104-9. PubMed ID: 16689183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. House dust mite subcutaneous immunotherapy does not induce new sensitization to tropomyosin: does it do the opposite?
    Pevec B; Pevec MR; Markovic AS; Batista I
    J Investig Allergol Clin Immunol; 2014; 24(1):29-34. PubMed ID: 24765878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and immunological differences between asymptomatic HDM-sensitized and HDM-allergic rhinitis patients.
    Zidarn M; Robič M; Krivec A; Šilar M; Resch-Marat Y; Vrtala S; Kopač P; Bajrović N; Valenta R; Korošec P
    Clin Exp Allergy; 2019 Jun; 49(6):808-818. PubMed ID: 30734376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of cytokine production in T-cell responses to inhalant allergen:GATA-3 expression distinguishes between Th1- and Th2-polarized immunity.
    Macaubas C; Holt PG
    Int Arch Allergy Immunol; 2001; 124(1-3):176-9. PubMed ID: 11306961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An evidence-based analysis of house dust mite allergen immunotherapy: a call for more rigorous clinical studies.
    Calderon MA; Casale TB; Nelson HS; Demoly P
    J Allergy Clin Immunol; 2013 Dec; 132(6):1322-36. PubMed ID: 24139829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lineage-specific regulation of allergic airway inflammation by the lipid phosphatase Src homology 2 domain-containing inositol 5-phosphatase (SHIP-1).
    Gold MJ; Hughes MR; Antignano F; Hirota JA; Zaph C; McNagny KM
    J Allergy Clin Immunol; 2015 Sep; 136(3):725-736.e2. PubMed ID: 25746967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of recombinant stable house dust mite allergen Der p 3 molecules for component-resolved diagnosis and specific immunotherapy.
    Bouaziz A; Walgraffe D; Bouillot C; Herman J; Foguenne J; Gothot A; Louis R; Hentges F; Jacquet A; Mailleux AC; Chevigné A; Galleni M; Adam E; Dumez ME
    Clin Exp Allergy; 2015 Apr; 45(4):823-34. PubMed ID: 25406386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.